Glen Kacher’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
Glen Kacher's CLBT Position: Q2 2026 in Review
Glen Kacher increased its Cellebrite (CLBT) stake by 105% in Q2 2026, buying an estimated $8.88M and bringing the position to 1,312,755 shares worth $19.2M. The position accounts for 2.12% of the portfolio, ranked #18.
Glen Kacher first reported a position in CLBT in Q3 2021 and has held it in 20 quarters since. The position peaked at $62.9M in Q3 2021. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- Glen Kacher held 1,312,755 shares of Cellebrite worth $19.2M as of Q2 2026.
- Glen Kacher bought 671,830 Cellebrite shares in Q2 2026, an estimated $8.88M.
- Cellebrite made up 2.12% of Glen Kacher's portfolio in Q2 2026, its #18 holding.
- Glen Kacher first reported a position in Cellebrite in Q3 2021 and has held it in 20 quarters since.
- Glen Kacher's Cellebrite position peaked at $62.9M in Q3 2021.
- 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on Light Street Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.